Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
626.00    -3.00 (-0.48%)
Bid:
624.00
Ask:
626.00
Spread: 2.00 (0.321%)
Market Cap: £1.15b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Trading Update

15 Apr 2021 07:00

RNS Number : 5159V
Volex PLC
15 April 2021
 

15 April 2021

 

Volex plc

 

Trading update

 

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is pleased to provide the following update on trading ahead of the scheduled announcement of the Group's full year results for the 52 weeks ended 4 April 20211 on 17 June 2021. 

 

Financial and operational performance

The Group delivered a robust performance in the second half of the financial year, underpinned by strong demand from customers in the consumer electronics and electric vehicle markets.

 

The performance for the period includes over $52 million of revenue from electric vehicle customers, a significant increase of 187% compared to the previous year, as we expanded our customer base and product offering in this market.

 

There has also been an overall stabilisation in demand from our core medical and industrial markets as well as healthy year-on-year growth from data centre customers as the trend towards home-working continues.

 

As a result, revenue for the full year will be ahead of market expectations and be at least $440 million while underlying operating profit is expected to be at least $41 million, ahead of the most recently guided range.

 

Margins benefited from foreign exchange movements and favourable commodity pricing in the first half of the financial year and, although these unwound in the second half as anticipated, the Group delivered strong year-on-year margin growth. The underlying operating margin achieved for the full year represents a satisfactory balance between revenue growth and profitability. 

Although the business and operational challenges posed by Covid-19 have not abated, all sites have remained fully operational even as our local teams have prioritised keeping our employees safe.

 

Acquisition activity and balance sheet

The acquisition of De-Ka Elektroteknik Sanayi ve Ticaret Anonim Şirketi ("DE-KA") completed on 18 February 2021 and its integration into the wider Volex business is progressing as planned, accelerating our strategy of creating the most efficient and lowest cost global producer in the industry.

 

DE-KA's sales and profits are currently significantly ahead of the previous year and the business continues to enjoy very strong demand in its core, white goods markets.

 

Following the acquisition of DE-KA, Group net debt (excluding lease liabilities) will be approximately $6 million. Having completed a successful refinancing in November 2020, Volex retains a high degree of financial flexibility and management continues to advance targeted investment opportunities, whilst maintaining its highly disciplined approach to potential acquisitions.

 

The Group expects to announce a recommended dividend for FY2021 that is no less than 2.2 pence per share.

 

Executive Chairman, Nat Rothschild commented:

"Volex delivered a particularly strong end to the period with our resilient business model meeting the challenges posed by the Covid-19 pandemic head-on. Robust demand in the electric vehicle and consumer electronics markets underpinned our performance in the second half and, thanks to our diverse customer base and global footprint, we are well placed to deliver on the next stage of our development as we look to increase investment and grow our business. Whilst we are now entering a more challenging inflationary environment, we aim to defend the significant margin gains we have made. Unless future lockdown measures severely disrupt our customers or operations, we are confident of further revenue and profit progression in FY2022."

 

This announcement, released by Volex plc, contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

For further information please contact: 

 

Volex plc +44 (0) 7747 488 785

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

 

Powerscourt - Media Enquiries +44 (0)20 7250 1446

James White

Jack Holden

 

N+1 Singer - Nominated Adviser and Joint Broker +44 (0)20 7496 3000

Shaun Dobson

Iqra Amin

 

HSBC Bank Plc - Joint Broker +44 (0)20 7991 8888

Simon Alexander

Joe Weaving

 

Notes:

1. All figures in this trading update are unaudited. Audited amounts will be included in our full year results announcement on 17 June 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFFISFISLIL
Date   Source Headline
13th Jun 20112:26 pmRNSPreference Share Dividend
7th Jun 20112:14 pmRNSVolex announces dividend and record payment dates
1st Jun 20117:00 amRNSPreliminary Results
14th Apr 20117:00 amRNSTrading Update
17th Feb 20114:10 pmRNSDirector/PDMR Shareholding
16th Feb 20111:33 pmRNSInvestor Seminar
16th Feb 20117:00 amRNSInterim Management Statement
6th Jan 20117:00 amRNSAppointment of Non - Executive Director
13th Dec 201012:07 pmRNSNotification of Major Interest in Shares
8th Dec 20107:00 amRNSRelease of Special Reserve
7th Dec 20107:00 amRNSNew Ordinary Shares issued
22nd Nov 201012:22 pmRNSNotification of Major Interest in Shares
22nd Nov 20107:00 amRNSVoting Rights and Capital
2nd Nov 20107:00 amRNSHalf-yearly results
5th Oct 20107:00 amRNSNew Share Issuance
1st Oct 20103:15 pmRNSResult of GM
23rd Sep 20107:00 amRNSAppointment
16th Sep 20107:00 amRNSNotice of General Meeting
25th Aug 20102:10 pmRNSDirector PDMR Shareholding
2nd Aug 20107:00 amRNSAnnual Information Update
27th Jul 20107:00 amRNSInterim Management Statement
26th Jul 20102:02 pmRNSSpecial Resolutions Passed at AGM
14th Jul 201011:53 amRNSResult of AGM
5th Jul 201011:19 amRNSRule 9.6.14
25th Jun 20104:49 pmRNSNotification of Major Interest in Shares
21st Jun 20109:49 amRNSNotification Of Major Interest In Shares
17th Jun 201010:52 amRNSAnnual Report and Accounts & Notice of AGM
10th Jun 20104:29 pmRNSNotification Of Major Interests In Shares
1st Jun 20107:00 amRNSPreliminary Results
19th May 20101:36 pmRNSBlock Listing Six Monthly Return
19th May 20101:35 pmRNSBlock Listing Six Monthly Return
26th Apr 201010:35 amRNSNotification Of Major Interest In Shares
19th Apr 20107:00 amRNSTrading Update
7th Apr 201010:00 amRNSAppointment of joint broker
29th Mar 20109:40 amRNSDirector/PDMR Shareholding
22nd Mar 20104:38 pmRNSHolding(s) in Company
18th Mar 20101:00 pmRNSPartnership with Huawei
3rd Mar 201012:13 pmRNSHolding(s) in Company
9th Feb 20107:00 amRNSInterim Management Statement
1st Feb 201012:00 pmRNSAward Win
25th Jan 20103:00 pmRNSHolding(s) in Company
12th Jan 20107:00 amRNSTrading Statement
11th Jan 201012:10 pmRNSHolding(s) in Company
5th Jan 20107:00 amRNSAward Win
29th Dec 200912:08 pmRNSHolding(s) in Company
18th Dec 20097:00 amRNSCompletion of management changes
18th Nov 20091:51 pmRNSChange of Registered Office
3rd Nov 20097:00 amRNSHalf Yearly Report
28th Oct 20092:42 pmRNSHolding(s) in Company
28th Oct 20092:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.